Earth Science Tech (ETST) Shares Outstanding (2011 - 2026)
Earth Science Tech's (ETST) quarterly Shares Outstanding (Entity) came in at $291.3 million in Q1 2026, down 1.36% YoY from $295.3 million in Q1 2025, and little changed on a QoQ basis from $291.6 million in Q4 2025.
Earth Science Tech (ETST) Shares Outstanding (2011 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 14 years of Shares Outstanding (Entity) data on file, last reported at $291.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) fell 1.36% year-over-year to $291.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $291.3 million (down 1.36% YoY) and the FY2026 annual result came in at $291.3 million, down 1.36% from the prior year.
- Shares Outstanding (Entity) steadied at $291.3 million in Q1 2026, from $291.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $314.9 million in Q4 2023 to a low of $53.9 million in Q1 2022.
- A 5-year average of $247.4 million and a median of $294.3 million in 2025 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) jumped 484.1% — and 2025, when it decreased 4.78%.
- Tracing ETST's Shares Outstanding (Entity) over 5 years: stood at $258.0 million in 2022, then climbed by 22.05% to $314.9 million in 2023, then decreased by 3.87% to $302.7 million in 2024, then slipped by 3.64% to $291.6 million in 2025, then slipped by 0.11% to $291.3 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $291.3 million (Q1 2026), $291.6 million (Q4 2025), and $292.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 832.44 Mn |
| 10 | Earth Science Tech | 35.67 Mn | 32.85 Mn | 6.28 Mn | 290.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 290.00 Mn |
| Mar 31, 2026 | 293.07 Mn |
| Dec 31, 2025 | 292.80 Mn |
| Sep 30, 2025 | 294.51 Mn |
| Jun 30, 2025 | 294.51 Mn |
| Mar 31, 2025 | 303.52 Mn |
| Dec 31, 2024 | 302.89 Mn |
| Sep 30, 2024 | 306.05 Mn |
| Jun 30, 2024 | 309.94 Mn |
| Mar 31, 2024 | 309.69 Mn |
| Dec 31, 2023 | 315.18 Mn |
| Sep 30, 2023 | 314.88 Mn |
| Jun 30, 2023 | 314.94 Mn |
| Mar 31, 2023 | 145.87 Mn |
| Sep 30, 2022 | 53.85 Mn |
| Jun 30, 2022 | 53.85 Mn |
| Mar 31, 2022 | 53.85 Mn |
| Jun 30, 2020 | 38.92 Mn |
| Mar 31, 2020 | 38.92 Mn |
| Dec 31, 2019 | 38.92 Mn |